Aug 10,2022

Factors predicting gains in moderate-to-vigorous physical activity in prostate cancer survivors on androgen deprivation therapy

This secondary analysis of a randomized controlled trial examined changes in MVPA following a supervised personal training (PT), supervised group-based (GROUP) program, or a home-based, smartphone-assisted exercise (HOME) intervention in PC survivors on ADT and explored individual, environmental, and psychosocial predictors of MVPA.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 18,2022

Delivery of cancer care via an outpatient telephone support line: a cross-sectional study of oncology nursing perspectives on quality and challenges

Patient support lines (PSLs) assist in triaging clinical problems, addressing patient queries, and navigating a complex multi-disciplinary oncology team. While providing support and training to the nursing staff who operate these lines is key, there is limited data on their experience and feedback. Despite high rates of satisfaction with the care provided by the PSL, the study identified several important areas for improvement which we feel warrant further investigation.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Aug 01,2022

Initial Analysis of Tumor Profiling From a Prospective Study by Foundation Medicine, Flatiron Health and Genentech Demonstrates Value of Tissue and Liquid Comprehensive Genomic Profiling in Patients with Advanced Non-Small Cell Lung Cancer

Foundation Medicine, Inc., Flatiron Health, and Genentech, members of the Roche Group, in partnership with a network of community oncology practices, today announced new research in the Journal of Thoracic Oncology Clinical and Research Reports on tumor profiling results from the ongoing, multicenter Prospective Clinicogenomic (PCG) Study (NCT04180176). In this investigation, researchers compared the ability of FoundationOne®CDx and FoundationOne®Liquid CDx comprehensive genomic profiling (CGP) to limited tissue testing in detecting actionable, guideline-recommended biomarkers for targeted treatment planning in patients with advanced non-squamous non-small cell lung cancer (aNSCLC). Results from this research reinforce that, in certain patient cases where an adequate tissue sample is immediately available, tissue CGP offers the most reliable detection of guideline-recommended biomarkers.

CLINICAL STUDY

#cdx

View Analyst & Ambassador Comments
Go to original news
Sep 05,2022

Results presented at ESMO 2022: Kaiku Health digital patient monitoring platform can help in resolving acute fever in melanoma patients

A multicenter study led by the Netherlands Cancer Institute used Kaiku Health digital patient management platform to investigate the use of digital patient monitoring and support of patients with advanced melanoma. The results published at ESMO 2022 annual conference suggest that Kaiku Health can be used to support patients and to collect real-world evidence. They can also help to understand the development of symptoms and quality of life of the patients. The study was a part of the Kaiku Health and Novartis collaboration announced in 2021. The results will be presented at the ESMO 2022 annual conference on Saturday, September 10, by the first author Judith Lijnsvelt from the Netherlands Cancer Institute.

CLINICAL STUDY

#ml

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 28,2022

Machine Learning Creates Opportunity for New Personalized Therapies

Researchers at the University of Michigan Rogel Cancer Center have developed a computational platform that can predict new and specific metabolic targets in ovarian cancer, suggesting opportunities to develop personalized therapies for patients that are informed by the genetic makeup of their tumors. The study appeared in Nature Metabolism.

CLINICAL STUDY

#ml

View Analyst & Ambassador Comments
Go to original news
Oct 31,2022 TOP STORY

AI Approach may Help Identify Melanoma Survivors who Face a High Risk of Cancer Recurrence

Most deaths from melanoma - the most lethal form of skin cancer - occur in patients who were initially diagnosed with early-stage melanoma and then later experienced a recurrence that is typically not detected until it has spread or metastasized. A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence - based method to predict which patients are most likely to experience a recurrence and are therefore expected to benefit from aggressive treatment. The method was validated in a study published in npj Precision Oncology.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Oct 27,2022 TOP STORY

Massive Bio Onboards Over 100,000 Cancer Patients to Find Their Clinical Trial, Powered by Artificial Intelligence

Massive Bio, a leader in AI-powered cancer clinical trial enrollment, today announced that the company exceeded its goal to onboard 100,000 cancer patients in its platform by the end of 2022 – nine months sooner than expected.

CLINICAL STUDY

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Jan 08,2021

Exploring Cancer Patients’ Perceptions of Accessing and Experience with Using the Educational Material in the Opal Patient Portal

Opal is a new patient-centered mobile application that gives cancer patients access to their real time medical data in conjunction with disease- and treatment-specific patient education material. Few studies have focused on patients’ experiences with such mobile applications. This study’s objectives were to (1) explore cancer patients’ perceptions of accessing the educational materials through Opal and (2) explore their experiences using these educational materials.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Jan 18,2021

A qualitative study of online support communities for lung cancer survivors on targeted therapies

Due to recent treatment advances, people who have non–small cell lung cancer with oncogenic alterations are an important new group of cancer survivors. Little is known about lung cancer online support communities. This research was guided by two primary questions: (1) How do these lung cancer survivors engage in online support communities? and (2) What are the psychological, social, and physical impacts of such engagement?

CLINICAL STUDY

#coaching

#platform

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

Web-based self-help intervention for partners of cancer patients based on acceptance and commitment therapy and self-compassion training: a randomized controlled trial with automated versus personal feedback

The study is to evaluate the effectiveness of two versions (personal or automated feedback) of a psychological Web-based self-help intervention targeting partners of cancer patients. The intervention was based on acceptance and commitment therapy (ACT) and self-compassion training. Participants’ adherence and their satisfaction were also studied.

CLINICAL STUDY

#mobile app

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to CLINICAL STUDY